APDN Receives Approval for TR8™ PGx Testing from NYS Dept of Health
STONY BROOK, N.Y. June 13, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health (“NYSDOH”) approved the Company’s TR8™ PGx (“TR8”) pharmacogenomic (PGx) testing service. The Company is currently in discussions to provide large-scale [...]